GL1X · GenesisL1 explorer

Research workbench

Hepatitis C virus polymerase NS5B genotype 1B (bk) in complex with inhibitor 2 (3-(3-tert-butyl-4-METHOXYPHENYL)PYRIDIN-2(1H)-one)

Analyse Hepatitis C virus polymerase NS5B genotype 1B (bk) in complex with inhibitor 2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MK7
Type
protein
Length
1,116 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
28O, MG
Pockets
15 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein55748% helix, 15% strandP26663
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55948% helix, 15% strandP26663

Ligands and binding sites

  • 28O · 3-(3-tert-butyl-4-methoxyphenyl)pyridin-2(1H)-one · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111500.810.8290DMS, 28O
25750.790.8564DMS, 28O
33220.610.7938empty
42020.610.8228empty
51140.510.8120empty

Interfaces

1 interface between chains.

  • A–B · 361 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4MK7 · Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.